{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:29:06Z","timestamp":1786480146424,"version":"build-2736575974"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001851","name":"Ministry of Earth Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001851","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000964","name":"Arthritis National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000964","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.mrfmmm.2026.111946","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:19:15Z","timestamp":1785424755000},"page":"111946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The role of KIT mutations in oral melanoma and disease progression: A literature review on early detection and targeted therapy"],"prefix":"10.1016","volume":"833","author":[{"given":"Sai","family":"Priyankha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanraj","family":"Ganapathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smitha","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9437-3382","authenticated-orcid":false,"given":"Pitchiah","family":"Sivaperumal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mrfmmm.2026.111946_bib1","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/odi.70105","article-title":"Prognostic predictors of oral mucosal melanoma\u2014A systematic review and meta-analysis","volume":"32","author":"Sebastian","year":"2026","journal-title":"Oral. Dis."},{"issue":"9","key":"10.1016\/j.mrfmmm.2026.111946_bib2","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s10495-025-02148-3","article-title":"Targeting ASK1 signaling in neurodegeneration: molecular insights and therapeutic promise","volume":"30","author":"Sulthana","year":"2025","journal-title":"Apoptosis"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib3","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1097\/JS9.0000000000001021","article-title":"A commentary on \u201cDoes the time interval between sentinel lymph node biopsy and completion lymph node dissection affect outcome in malignant melanoma? A retrospective cohort study\u201d \u2013 correspondence","volume":"110","author":"Saravanan","year":"2024","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib4","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev-pathmechdis-031521-041424","article-title":"Oropharyngeal carcinoma with a special focus on HPV-related squamous cell carcinoma","volume":"18","author":"Ferris","year":"2023","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/path.5505","article-title":"Spontaneously occurring melanoma in animals and their relevance to human melanoma","volume":"252","author":"van der Weyden","year":"2020","journal-title":"J. Pathol."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib6","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3390\/jcm10030478","article-title":"Cutaneous and mucosal melanomas of uncommon sites: Where do we stand now?","volume":"10","author":"Dika","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.amsu.2021.01.026","article-title":"Melanoma of the oral cavity: A silent killer","volume":"62","author":"Aloua","year":"2021","journal-title":"Ann. Med. Surg. (Lond. )"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib9","series-title":"in: Diseases of the Oral Mucosa","first-page":"371","article-title":"Melanoma of the oral cavity","author":"Langan","year":"2021"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib10","series-title":"in: Oral Medicine - A Clinical Guide","first-page":"245","article-title":"Common Causes of Oral Pigmentation","author":"Clayden","year":"2023"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib11","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.bjoms.2020.05.028","article-title":"Survival of oral mucosal melanoma according to treatment, tumour resection margin, and metastases","volume":"58","author":"Chae","year":"2020","journal-title":"Br. J. Oral. Maxillofac. Surg."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib12","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/03009858211009784","article-title":"Correlation between KIT expression and c-Kit mutations in 2 subtypes of canine oral melanocytic neoplasms","volume":"58","author":"Smedley","year":"2021","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib13","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3390\/cancers17061008","article-title":"Translational advances in oncogene and tumor-suppressor gene research","volume":"17","author":"Stojchevski","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib14","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1158\/1541-7786.MCR-20-0839","article-title":"Meta-analysis and systematic review of the genomics of mucosal melanoma","volume":"19","author":"Broit","year":"2021","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib15","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/s41416-022-01942-z","article-title":"Clinical and genomic correlates of imatinib response in melanomas with KIT alterations","volume":"127","author":"Jung","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/jmp6030020","article-title":"The future of cancer diagnosis and treatment: Unlocking the power of biomarkers and personalized molecular-targeted therapies","volume":"6","author":"Molla","year":"2025","journal-title":"J. Mol. Pathol. (Basel)"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib17","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-023-01411-x","article-title":"KIT mutations and expression: current knowledge and new insights for overcoming IM resistance in GIST","volume":"22","author":"Zhou","year":"2024","journal-title":"Cell. Commun. Signal."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.153311","article-title":"Prognostic immunohistochemical markers for small cell lung cancer: A review","volume":"217","author":"Yuan","year":"2021","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib19","doi-asserted-by":"crossref","DOI":"10.17305\/bjbms.2021.7399","article-title":"Role and significance of c-KIT receptor tyrosine kinase in cancer: A review","author":"Sheikh","year":"2022","journal-title":"Bosn. J. Basic. Med. Sci."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib20","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3349\/ymj.2020.61.7.562","article-title":"KIT and melanoma: Biological insights and clinical implications","volume":"61","author":"Pham","year":"2020","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib21","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4103\/JIOH.JIOH_6_21","article-title":"c-KIT mutation role in oral malignant melanoma pathway: A narrative review","volume":"13","author":"Gofur","year":"2021","journal-title":"J. Int. Oral. Health"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2478\/amma-2024-0025","article-title":"Identification and expression of microRNA-34a-3p and its target Rapamycin-insensitive companion of mTOR (RICTOR) in polycystic ovarian syndrome in South Indian population","volume":"70","author":"Saravanan","year":"2024","journal-title":"Acta Marisiensis Ser. Med."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4103\/jomfp.jomfp_41_25","article-title":"Deoxyelephantopin induces cell death in oral cancer cells via the downregulation of AKT1-mTOR-mediated mechanisms","volume":"29","author":"Jayaraman","year":"2025","journal-title":"J. Oral. Maxillofac. Pathol."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2020.100125","article-title":"TARGET-seq: A protocol for high-sensitivity single-cell mutational analysis and parallel RNA sequencing","volume":"1","author":"Rodriguez-Meira","year":"2020","journal-title":"STAR Protoc."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/2270965","article-title":"Confirming multiplex RT-qPCR use in COVID-19 with next-Generation Sequencing: Strategies for epidemiological advantage","volume":"2022","author":"Carpenter","year":"2022","journal-title":"Glob. Health Epidemiol. Genom."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib27","doi-asserted-by":"crossref","first-page":"10931","DOI":"10.3390\/ijms222010931","article-title":"Cancer therapy guided by mutation tests: Current status and perspectives","volume":"22","author":"Aleksakhina","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib28","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1002\/cncr.32735","article-title":"Core needle biopsy versus incisional biopsy for differentiation of soft-tissue sarcomas: a systematic review and meta-analysis","volume":"126","author":"Birgin","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib29","first-page":"997","article-title":"Next-generation sequencing technology: Current trends and advancements","volume":"12","author":"Satam","year":"2023","journal-title":"Biol. (Basel)"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib30","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3390\/cancers13050993","article-title":"Type and gene location of KIT mutations predict progression-free survival to first-line imatinib in gastrointestinal stromal tumors: a look into the Exon","volume":"13","author":"Incorvaia","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib31","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41576-024-00748-4","article-title":"Methods and applications of genome-wide profiling of DNA damage and rare mutations","volume":"25","author":"Pfeifer","year":"2024","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib32","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.3390\/cancers15072074","article-title":"Molecular tailored therapeutic options for advanced gastrointestinal stromal tumors (GISTs): Current practice and future perspectives","volume":"15","author":"Catalano","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib33","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.3390\/cells10092216","article-title":"Prognostic roles of BRAF, KIT, NRAS, IGF2R and SF3B1 mutations in mucosal melanomas","volume":"10","author":"Wr\u00f3blewska","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib34","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/his.15456","article-title":"Unveiling the molecular landscape and clinically relevant molecular heterogeneity of mucosal melanoma of the head and neck region","volume":"87","author":"Ricci","year":"2025","journal-title":"Histopathology"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib35","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/s41379-022-01122-7","article-title":"Alterations in key signaling pathways in sinonasal tract melanoma. A molecular genetics and immunohistochemical study of 90 cases and comprehensive review of the literature","volume":"35","author":"Ch\u0142opek","year":"2022","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib36","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.3390\/cells10092320","article-title":"Molecular markers and targets in melanoma","volume":"10","author":"Teixido","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib37","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.3390\/cancers13071685","article-title":"RTK inhibitors in melanoma: From bench to bedside","volume":"13","author":"Sabbah","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib38","doi-asserted-by":"crossref","DOI":"10.1186\/s43556-022-00110-2","article-title":"Targeting the PI3K\/AKT\/mTOR and RAF\/MEK\/ERK pathways for cancer therapy","volume":"3","author":"Li","year":"2022","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.446","article-title":"Receptor tyrosine kinases: biological functions and anticancer targeted therapy","volume":"4","author":"Zhang","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib40","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1158\/1078-0432.CCR-21-2275","article-title":"Predictable clinical benefits without evidence of synergy in trials of combination therapies with immune-checkpoint inhibitors","volume":"28","author":"Palmer","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12041009","article-title":"Personalized medicine: recent progress in cancer therapy","volume":"12","author":"Gambardella","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib42","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3390\/cancers13051115","article-title":"Resistance to molecularly targeted therapies in melanoma","volume":"13","author":"Patel","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib43","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.3390\/cancers14153779","article-title":"Treatment of metastatic melanoma with a combination of immunotherapies and molecularly targeted therapies","volume":"14","author":"Rager","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib44","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3390\/biom15010120","article-title":"Acral melanoma: a review of its pathogenesis, progression, and management","volume":"15","author":"Kim","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1340408","article-title":"Multidisciplinary approach and treatment of acral and mucosal melanoma","volume":"14","author":"Fortuna","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib46","doi-asserted-by":"crossref","first-page":"15945","DOI":"10.1002\/cam4.6234","article-title":"A real-world study of adjuvant anti-PD -1 immunotherapy on stage III melanoma with BRAF, NRAS, and KIT mutations","volume":"12","author":"Sun","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib47","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.3390\/cancers14133066","article-title":"GNAQ and GNA11 genes: a comprehensive review on oncogenesis, prognosis and therapeutic opportunities in uveal melanoma","volume":"14","author":"Silva-Rodr\u00edguez","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111055","article-title":"Targeting PI3K\/AKT\/mTOR signaling to overcome drug resistance in cancer","volume":"396","author":"Tufail","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib49","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2077898","article-title":"Trial Watch: combination of tyrosine kinase inhibitors (TKIs) and immunotherapy","volume":"11","author":"Petrazzuolo","year":"2022","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.891580","article-title":"CDK4\/6 inhibitors in combination therapies: Better in company than alone: A mini review","volume":"12","author":"Rampioni Vinciguerra","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib51","article-title":"Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective","volume":"7","author":"Yang","year":"2022","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.931774","article-title":"Onco-immunomodulatory properties of pharmacological interference with RAS-RAF-MEK-ERK pathway hyperactivation","volume":"12","author":"Avery","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib53","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1158\/2159-8290.CD-20-0873","article-title":"Durable suppression of acquired MEK inhibitor resistance in cancer by sequestering MEK from ERK and promoting antitumor T-cell immunity","volume":"11","author":"Hong","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252689","article-title":"Inhibition of PI3K and MAPK pathways along with KIT inhibitors as a strategy to overcome drug resistance in gastrointestinal stromal tumors","volume":"16","author":"Gupta","year":"2021","journal-title":"PLoS. One"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-021-04206-5","article-title":"Alpelisib combination treatment as novel targeted therapy against hepatocellular carcinoma","volume":"12","author":"Xu","year":"2021","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib56","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-021-02407-8","article-title":"Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier","volume":"22","author":"Vafaei","year":"2022","journal-title":"Cancer Cell. Int."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.905947","article-title":"Recent advancements of monotherapy, combination, and sequential treatment of EGFR\/ALK-TKIs and ICIs in non\u2013small cell lung cancer","volume":"13","author":"Liao","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib58","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.3390\/cancers15102718","article-title":"Beyond CTLA-4 and PD-1 inhibition: Novel immune checkpoint molecules for melanoma treatment","volume":"15","author":"Ziogas","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib59","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3390\/cancers13061203","article-title":"Immunosuppressive cell subsets and factors in myeloid leukemias","volume":"13","author":"Swatler","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib60","doi-asserted-by":"crossref","unstructured":"D. Ti, Department of Bio-therapeutic, the First Medical Center, Chinese PLA General Hospital, Beijing 100853, China, (b)X. Yan, J. Wei, Z. Wu, Y. Wang, W. Han, Inducing immunogenic cell death in immuno-oncological therapies, Chin. J. Cancer Res. 34 (2022) 1\u201310. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2022.01.01.","DOI":"10.21147\/j.issn.1000-9604.2022.01.01"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib61","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.3390\/cancers13205225","article-title":"Currently used laboratory methodologies for assays detecting PD-1, PD-L1, PD-L2 and soluble PD-L1 in patients with metastatic breast cancer","volume":"13","author":"Jeong","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib62","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.critrevonc.2017.01.019","article-title":"Mucosal melanoma of the head and neck","volume":"112","author":"Ascierto","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib63","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/CMR.0b013e32834b58cf","article-title":"Mucosal melanomas of the head and neck: new aspects of the clinical outcome, molecular pathology, and treatment with c-kit inhibitors","volume":"21","author":"Papaspyrou","year":"2011","journal-title":"Melanoma Res."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib64","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0000000000002032","article-title":"PRAME expression in mucosal MElanoma of the head and neck region","volume":"47","author":"Ricci","year":"2023","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib65","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/jop.12526","article-title":"An update on the current management of head and neck mucosal melanoma","volume":"46","author":"Green","year":"2017","journal-title":"J. Oral. Pathol. Med."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib66","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/00016489.2021.2015540","article-title":"Gene mutations and clinical prognosis of mucosal melanoma in different locations of head and neck","volume":"142","author":"Guo","year":"2022","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib67","article-title":"Association of survival and immune-related adverse events with anti-PD-1\/PD-L1 and anti-CTLA-4 inhibitors, alone or their combination for the treatment of cancer: A systematic review and meta-analysis of 13 clinical trials","volume":"11","author":"Zhang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib68","article-title":"Immunogenic cell death activates the tumor immune microenvironment to boost the immunotherapy efficiency","volume":"9","author":"Li","year":"2022","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib69","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.3390\/molecules27082466","article-title":"Application of approved Cisplatin derivatives in combination therapy against different cancer diseases","volume":"27","author":"Tsvetkova","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib70","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10549-021-06423-0","article-title":"Emerging combination immunotherapy strategies for breast cancer: dual immune checkpoint modulation, antibody\u2013drug conjugates and bispecific antibodies","volume":"191","author":"Torres","year":"2022","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib71","doi-asserted-by":"crossref","DOI":"10.1111\/pcmr.70017","article-title":"Oral melanoma in older adults: Epidemiology, molecular landscape, and treatment strategies","volume":"38","author":"de Arruda","year":"2025","journal-title":"Pigment. Cell. Melanoma Res."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib72","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.3390\/cancers7030860","article-title":"Targeting RTK signaling pathways in cancer","volume":"7","author":"Regad","year":"2015","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib73","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","article-title":"Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies","volume":"8","author":"Bahar","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib74","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11912-020-01008-4","article-title":"Tumor and systemic immunomodulatory effects of MEK inhibition","volume":"23","author":"Dennison","year":"2021","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.181","article-title":"Small molecule inhibitors targeting the cancers","volume":"3","author":"Liu","year":"2022","journal-title":"MedComm"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib76","first-page":"13","article-title":"Immune checkpoint inhibitors in metastatic melanoma therapy (Review)","volume":"4","author":"Shah","year":"2024","journal-title":"Med. Int. (Lond. )"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.830208","article-title":"Key players of the immunosuppressive tumor microenvironment and emerging therapeutic strategies","volume":"10","author":"Park","year":"2022","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib78","article-title":"Combination therapy of TKIs and ICIs for the treatment of anaplastic thyroid carcinoma","volume":"15","author":"Zhang","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib79","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3389\/fimmu.2019.00453","article-title":"Combining immune checkpoint inhibitors: established and emerging targets and strategies to improve outcomes in melanoma","volume":"10","author":"Khair","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib80","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.3390\/jcm13216537","article-title":"Next-generation immunotherapy: advancing clinical applications in cancer treatment","volume":"13","author":"Garg","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib81","article-title":"Radiotherapy as an immunomodulator in cancer: synergy with immunotherapy and roadmap for optimization","volume":"19","author":"Zhao","year":"2026","journal-title":"J. Radiat. Res. Appl. Sci."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib82","series-title":"in: Melanoma - Recent Advances, New Perspectives and Applications [Working Title]","article-title":"Oral melanomas: clinical insights and therapeutic perspectives","author":"Mahesh","year":"2025"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib83","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-17394-7","article-title":"Real-world evidence of the intrinsic limitations of PCR-based EGFR mutation assay in non-small cell lung cancer","volume":"12","author":"Shen","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib84","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.cell.2024.02.041","article-title":"Cancer biomarkers: emerging trends and clinical implications for personalized treatment","volume":"187","author":"Passaro","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.mrfmmm.2026.111946_bib85","doi-asserted-by":"crossref","DOI":"10.1200\/EDBK-25-473858","article-title":"Therapeutic approaches to mucosal melanoma","volume":"45","author":"Lian","year":"2025","journal-title":"Am. Soc. Clin. Oncol. Educ. Book."},{"key":"10.1016\/j.mrfmmm.2026.111946_bib86","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41392-024-01856-7","article-title":"Exploring treatment options in cancer: tumor treatment strategies","volume":"9","author":"Liu","year":"2024","journal-title":"Signal. Transduct. Target. Ther."}],"container-title":["Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386196426000199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386196426000199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:48:25Z","timestamp":1786477705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386196426000199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":84,"alternative-id":["S1386196426000199"],"URL":"https:\/\/doi.org\/10.1016\/j.mrfmmm.2026.111946","relation":{},"ISSN":["1386-1964"],"issn-type":[{"value":"1386-1964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of KIT mutations in oral melanoma and disease progression: A literature review on early detection and targeted therapy","name":"articletitle","label":"Article Title"},{"value":"Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mrfmmm.2026.111946","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111946"}}